UWM Holdings Corp (UWMC) Form 8-K — Oct 23, 2026
$UWMCForm 8-KItems 2.02, 8.01, 9.01Filed Oct 23, 2026, 8:43 AM ET0001783398-26-000128Original filing
UWM Holdings announced preliminary Q3 2026 results: $33.4 billion in originations, $800-825 million total revenue, and net income of $205-220 million, with a gain margin of roughly 124 basis points and a $270 billion MSR portfolio. The company also updated full-year guidance, cutting expected 2026 revenue to $3.35-3.50 billion due to lower industry origination volume, while planning $70-80 billion of MSR sales in Q4 for proceeds exceeding $1.8 billion to pay down non-funding debt.
Key figures
- Eps
- 0
- Revenue
- 800-825 million (Q3 2026 preliminary)
- Guidance
- FY2026 total revenue approximately $3.35-$3.50 billion, lower than expected earlier in 2026; ~8% of US residential mortgage production; MSR portfolio $210-$230 billion UPB at year-end; $70-80 billion MSR sales in Q4 2026 with proceeds in excess of $1.8 billion
- Net Income
- 205-220 million (Q3 2026 preliminary)
- Total Debt
- 16955000000
- Total Assets
- 17941000000
- Cash Position
- 498 million (2Q26)
- Gross Proceeds
- up to 400 million (rights offering)
- Offering Price
- greater of $2.00 and 85% of 10-day VWAP
- Shares Offered
- 200 million Class A shares via rights offering
- Shares Outstanding
- 0
- Rights ratio
- 0.57 shares per subscription right
- Q3 gain margin
- ~124 bps
- Msr portfolio upb
- ~$270 billion at Sept 30, 2026
- Q3 adjusted ebitda
- $170-190 million
- Q3 operating expenses
- $375-385 million
- Msr weighted avg coupon
- 5.97%
- Q3 loan origination volume
- $33.4 billion ($22.8B purchase, $10.6B refinance)
- Redeemable preferred stock
- $1.5 billion
- Rights offering expiration
- November 12, 2026
- Series a preferred investment
- $1.65 billion (closed August 5, 2026)
- Net non funding debt to equity
- 1.75x-1.80x
- Total preferred and common equity
- ~$2.8 billion
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.